Abstract
Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction. The 'no-reflow' phenomenon disappeared after nicorandil administration and significant functional recovery of the infarcted myocardium was achieved. This suggests that nicorandil could eliminate the 'no-reflow' phenomenon after successful coronary revascularization.
MeSH terms
-
Coronary Circulation / drug effects*
-
Coronary Vessels
-
Humans
-
Injections
-
Male
-
Middle Aged
-
Myocardial Infarction / diagnostic imaging
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / physiopathology
-
Myocardial Reperfusion
-
Niacinamide / administration & dosage
-
Niacinamide / analogs & derivatives*
-
Niacinamide / therapeutic use
-
Nicorandil
-
Potassium Channels / agonists*
-
Thrombolytic Therapy
-
Ultrasonography
Substances
-
Potassium Channels
-
Niacinamide
-
Nicorandil